ARTICLE | Distillery Therapeutics
Cancer
October 27, 2016 7:00 AM UTC
In vitro, cell culture and mouse studies identified a dual CREBBP/EP300 inhibitor that could help treat AML, myeloma and lymphoma. Screening of a small molecule library and in vitro testing in competi...
BCIQ Company Profiles